CIK 0001176309 · Non-accelerated filer<br>Smaller reporting company
ORAMED PHARMACEUTICALS INC.
Sign in to watch- Ticker
- ORMP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980376008
- Phone
- 646-844-1164
- Business address
- 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
- Former names
- Integrated Security Technologies, Inc., IGUANA VENTURES LTD
- 4 Grant or award President and CEO acquired 279,000 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 213,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 97,500 shares (grant or award)
- 4 Grant or award Director acquired 30,000 shares (grant or award)
- 4 Open-market buy Director bought 8,809 shares at an average $2.22 ($19,518)
- 4 Open-market buy President and CEO bought 26,000 shares at $2.04 ($53,014)
- 4 Open-market buy President and CEO bought 100,000 shares at $2.01 ($201,000)
- 4 Open-market sale Chief Scientific Officer sold 100,000 shares at $2.01 ($201,000)
- 4 Open-market buy Director bought 70,000 shares at an average $2.02 ($141,570)
- 4 Open-market sale Chief Commercial Officer sold 13,325 shares at an average $12.55 ($167,195)
- 4 Gift President and CEO gave 25,000 shares (gift)
- 4 Option exercise Director acquired 20,000 shares (option exercise)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 30,000 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 118,000 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 12,631 shares (to pay taxes)
- 4 Grant or award COO & CBO acquired 42,000 shares (grant or award)
- 4 Grant or award Director acquired 12,000 shares (grant or award)
Page 5 of 16 · 306 filings